Clenoliximab
Clenoliximab (IDEC-151) is a macaque-human chimeric monoclonal antibody (immunoglobulin G4) specific for the CD4 molecule on the surface of T lymphocytes. Clenoliximab can be used for the research of rheumatoid arthritis[1].
Product Specifications
CAS Number
182912-58-9
Product Name Alternative
IDEC-151
UNSPSC
12352203
Target
HIV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/clenoliximab.html
Solubility
10 mM in DMSO
Smiles
[Clenoliximab]
References & Citations
[1]D R Mould, et al. A population pharmacokinetic-pharmacodynamic analysis of single doses of clenoliximab in patients with rheumatoid arthritis. Clin Pharmacol Ther. 1999 Sep;66 (3) :246-57.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-A938150-10MG 10 mg
(1R,2R)-2-Aminocyclopentanecarboxylic acid hydrochloride
Sign In for Pricing
View Details 